Production and Quality Control of Fluorine-18 Labelled Radiopharmaceuticals
Seiten
2021
IAEA (Verlag)
978-92-0-122721-8 (ISBN)
IAEA (Verlag)
978-92-0-122721-8 (ISBN)
- Titel z.Zt. nicht lieferbar
- Portofrei ab CHF 40
- Auch auf Rechnung
- Artikel merken
Describes the chemical and biological properties of F-18 radiopharmaceuticals. This includes aspects relating to F-18 target production and radiofluorination methods, with focus on the applied techniques. The publication presents a disease oriented approach, describing F-18 radiopharmaceuticals.
Since their clinical use initiation in the 1970's, Fluorine-18 (F-18) radiopharmaceuticals continue to play an important role in nuclear medicine. It is therefore essential to make available broad information on practical production routes and optimal quality control for F- 18 tracers, to achieve the best possible products in high quantity and quality for clinical applications while fulfilling all regulatory requirements. This publication describes the chemical and biological properties of F-18 radiopharmaceuticals. This includes aspects relating to F-18 target production and radiofluorination methods, with focus on the applied techniques. The publication presents a disease oriented approach, describing F-18 radiopharmaceuticals, ranging from the physiological/biological aspects to dedicated radiopharmaceutical development approaches and provides readers with clear guidelines and methods for the production of F-18 radiopharmaceuticals.
Since their clinical use initiation in the 1970's, Fluorine-18 (F-18) radiopharmaceuticals continue to play an important role in nuclear medicine. It is therefore essential to make available broad information on practical production routes and optimal quality control for F- 18 tracers, to achieve the best possible products in high quantity and quality for clinical applications while fulfilling all regulatory requirements. This publication describes the chemical and biological properties of F-18 radiopharmaceuticals. This includes aspects relating to F-18 target production and radiofluorination methods, with focus on the applied techniques. The publication presents a disease oriented approach, describing F-18 radiopharmaceuticals, ranging from the physiological/biological aspects to dedicated radiopharmaceutical development approaches and provides readers with clear guidelines and methods for the production of F-18 radiopharmaceuticals.
| Erscheinungsdatum | 06.05.2022 |
|---|---|
| Reihe/Serie | IAEA TECDOC |
| Zusatzinfo | 118 illustrations |
| Verlagsort | Vienna |
| Sprache | englisch |
| Maße | 210 x 297 mm |
| Gewicht | 470 g |
| Themenwelt | Medizinische Fachgebiete ► Radiologie / Bildgebende Verfahren ► Nuklearmedizin |
| Naturwissenschaften ► Physik / Astronomie ► Atom- / Kern- / Molekularphysik | |
| Technik ► Elektrotechnik / Energietechnik | |
| ISBN-10 | 92-0-122721-3 / 9201227213 |
| ISBN-13 | 978-92-0-122721-8 / 9789201227218 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Buch | Softcover (2022)
Lehmanns Media (Verlag)
CHF 55,90
Buch | Softcover (2022)
Facultas (Verlag)
CHF 43,50
